Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.

Atkins MB, Ernstoff MS, Figlin RA, Flaherty KT, George DJ, Kaelin WG, Kwon ED, Libermann TA, Linehan WM, McDermott DF, Ochoa AC, Pantuck AJ, Rini BI, Rosen MA, Sosman JA, Sukhatme VP, Vieweg JW, Wood CG, King L
Clin Cancer Res. 2007 13 (2 Pt 2): 667s-670s

PMID: 17255291 · DOI:10.1158/1078-0432.CCR-06-2231

Innovations and Challenges in Renal Cancer, chaired by Michael B. Atkins, was held April 28 to 29, 2006 in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, urology, immunology, radiology, and immunotherapy, with the goal of advancing the field of renal cancer treatment by critiquing new data from ongoing clinical trials and stimulating communication among those involved in basic and clinical research. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on important aspects of renal cancer genetics and biology and advances in prognostic classification and treatment.

MeSH Terms (8)

Angiogenesis Inhibitors Antineoplastic Agents Carcinoma, Renal Cell Humans Models, Biological Mutation Neoplasm Metastasis Prognosis

Connections (1)

This publication is referenced by other Labnodes entities: